Biswas Subrata, DiSilvestre Deborah, Tian Yanli, Halperin Victoria L, Tomaselli Gordon F
Department of Medicine, Division of Cardiology, Johns Hopkins University, Baltimore, Md. 21205, USA.
Circ Res. 2009 Apr 10;104(7):870-8. doi: 10.1161/CIRCRESAHA.108.193565. Epub 2009 Mar 5.
Intracellular Ca(2+) (Ca(2+)) can trigger dual-mode regulation of the voltage gated cardiac sodium channel (Na(V)1.5). The channel components of the Ca(2+) regulatory system are the calmodulin (CaM)-binding IQ motif and the Ca(2+) sensing EF hand-like (EFL) motif in the carboxyl terminus of the channel. Mutations in either motif have been associated with arrhythmogenic changes in expressed Na(V)1.5 currents. Increases in Ca(2+) shift the steady-state inactivation of Na(V)1.5 in the depolarizing direction and slow entry into inactivated states. Mutation of the EFL (Na(V)1.5(4X)) shifts inactivation in the hyperpolarizing direction compared with the wild-type channel and eliminates the Ca(2+) sensitivity of inactivation gating. Modulation of the steady-state availability of Na(V)1.5 by Ca(2+) is more pronounced after the truncation of the carboxyl terminus proximal to the IQ motif (Na(V)1.5(Delta1885)), which retains the EFL. Mutating the EFL (Na(V)1.5(4X)) unmasks CaM-mediated regulation of the kinetics and voltage dependence of inactivation. This latent CaM modulation of inactivation is eliminated by mutation of the IQ motif (Na(V)1.5(4X-IQ/AA)). The LQT3 EFL mutant channel Na(V)1.5(D1790G) exhibits Ca(2+) insensitivity and unmasking of CaM regulation of inactivation gating. The enhanced effect of CaM on Na(V)1.5(4X) gating is associated with significantly greater fluorescence resonance energy transfer between enhanced cyan fluorescent protein-CaM and Na(V)1.5(4X) channels than is observed with wild-type Na(V)1.5. Unlike other isoforms of the Na channel, the IQ-CaM interaction in the carboxyl terminus of Na(V)1.5 is latent under physiological conditions but may become manifest in the presence of disease causing mutations in the CT of Na(V)1.5 (particularly in the EFL), contributing to the production of potentially lethal ventricular arrhythmias.
细胞内钙离子([Ca²⁺]i)可触发电压门控心脏钠通道(NaV1.5)的双模式调节。Ca²⁺调节系统的通道组件是通道羧基末端的钙调蛋白(CaM)结合IQ基序和Ca²⁺感应EF手样(EFL)基序。任一基序中的突变都与表达的NaV1.5电流的致心律失常变化有关。[Ca²⁺]i升高会使NaV1.5的稳态失活向去极化方向移动,并减缓进入失活状态的速度。与野生型通道相比,EFL突变体(NaV1.5(4X))使失活向超极化方向移动,并消除了失活门控的Ca²⁺敏感性。在靠近IQ基序的羧基末端被截断后(NaV1.5(Δ1885),其保留了EFL),[Ca²⁺]i对NaV1.5稳态可用性的调节更为明显。突变EFL(NaV1.5(4X))会揭示CaM对失活动力学和电压依赖性的调节作用。通过突变IQ基序(NaV1.5(4X-IQ/AA))可消除这种潜在的CaM对失活的调节作用。长QT综合征3型EFL突变通道NaV1.5(D1790G)表现出Ca²⁺不敏感性,并揭示了CaM对失活门控的调节作用。与野生型NaV1.5相比,CaM对NaV1.5(4X)门控的增强作用与增强型青色荧光蛋白-CaM和NaV1.5(4X)通道之间显著更大的荧光共振能量转移有关。与钠通道的其他亚型不同,NaV1.5羧基末端的IQ-CaM相互作用在生理条件下是潜在的,但在NaV1.5的CT存在致病变异(特别是在EFL中)时可能会显现出来,从而导致潜在致命性室性心律失常的产生。